We are live on
!
Find out more
Wealth Enhancement Advisory Services Portfolio holdings
AUM
$59.8B
1-Year Est. Return
29.42%
This Fund
S&P 500
This Quarter
Est. Return
+16.32%
1 Year Est. Return
+29.42%
3 Year Est. Return
+77.06%
5 Year Est. Return
+66.38%
10 Year Est. Return
+178.95%
AUM
$59.8B
AUM Growth
+$10.7B
(+22%)
Cap. Flow
+$5.19B
Cap. Flow
% of AUM
8.67%
Top 10 Holdings %
Top 10 Hldgs %
23.53%
Holding
4,265
New
679
Increased
2,387
Reduced
954
Closed
129
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$324M |
| 2 |
Apple
AAPL
|
+$243M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$224M |
| 4 |
ALPS Smith Core Plus Bond ETF
SMTH
|
+$197M |
| 5 |
Applied Materials
AMAT
|
+$187M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$490M |
| 2 |
KLA
KLAC
|
+$206M |
| 3 |
Amphenol
APH
|
+$149M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$130M |
| 5 |
Bank of America
BAC
|
+$61.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.05% |
| 2 | Financials | 6.1% |
| 3 | Industrials | 4.95% |
| 4 | Healthcare | 4.22% |
| 5 | Consumer Discretionary | 3.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3951
INmune Bio
INMB
$43.1M
| $39.7K | ﹤0.01% |
+20,449
| New | +$28.3K |
|
3952
Prairie Operating Co
PROP
$78.2M
| $39.3K | ﹤0.01% |
53,880
+41,374
| +331% | +$44.6K |
|
|
ESPR
3953
DELISTED
Esperion Therapeutics
ESPR
| $39.2K | ﹤0.01% |
12,321
-11,647
| -49% | -$32.6K |
|
3954
Standard BioTools
LAB
$326M
| $38.7K | ﹤0.01% |
42,090
+11,631
| +38% | +$11K |
|
3955
Inhibikase Therapeutics
IKT
$366M
| $38.3K | ﹤0.01% |
+18,759
| New | +$33.6K |
|
3956
Rocky Mountain Chocolate Factory
RMCF
$8.53M
| $37.9K | ﹤0.01% |
+33,576
| New | +$67.6K |
|
3957
CALL
Hims & Hers Health
HIMS
$6.5B
| $37.8K | ﹤0.01% |
+1,100
| New | +$29.5K |
|
3958
Rafael Holdings
RFL
$111M
| $37.8K | ﹤0.01% |
16,937
-1,662
| -9% | -$2.67K |
|
3959
Getty Images
GETY
$184M
| $37.6K | ﹤0.01% |
49,377
+4,697
| +11% | +$4.07K |
|
3960
Claros Mortgage Trust
CMTG
$306M
| $37.1K | ﹤0.01% |
16,634
+4,478
| +37% | +$11K |
|
3961
PUT
VanEck Gold Miners ETF
GDX
$23B
| $36.6K | ﹤0.01% |
+500
| New | +$44.2K |
|
3962
Lifezone Metals
LZM
$291M
| $36.2K | ﹤0.01% |
+10,272
| New | +$48K |
|
3963
CALL
Palantir
PLTR
$295B
| $36.1K | ﹤0.01% |
+300
| New | +$40.9K |
|
3964
Fulcrum Therapeutics
FULC
$248M
| $35.9K | ﹤0.01% |
+10,254
| New | +$62.4K |
|
3965
Pulmonx
LUNG
$49.4M
| $35.8K | ﹤0.01% |
+23,233
| New | +$32K |
|
3966
BioLife Solutions
BLFS
$1.46B
| $35.5K | ﹤0.01% |
16,162
+503
| +3% | +$11.8K |
|
3967
Denison Mines
DNN
$2.63B
| $35K | ﹤0.01% |
10,821
-300
| -3% | -$1.04K |
|
3968
Humacyte
HUMA
$168M
| $34.7K | ﹤0.01% |
50,030
-28,574
| -36% | -$26.5K |
|
3969
CALL
Huntington Bancshares
HBAN
$35.1B
| $34.5K | ﹤0.01% |
+2,000
| New | +$33K |
|
3970
eHealth
EHTH
$42.5M
| $34.4K | ﹤0.01% |
21,231
+4,185
| +25% | +$7.01K |
|
3971
SelectQuote
SLQT
$114M
| $33.7K | ﹤0.01% |
43,799
+22,799
| +109% | +$20.8K |
|
3972
Myomo
MYO
$37.5M
| $33.4K | ﹤0.01% |
30,389
+19,063
| +168% | +$18.6K |
|
3973
CALL
Fidelity Wise Origin Bitcoin Fund
FBTC
$11.9B
| $33.4K | ﹤0.01% |
+600
| New | +$37.5K |
|
3974
Kaltura
KLTR
$211M
| $33.4K | ﹤0.01% |
26,058
+10,090
| +63% | +$13.7K |
|
3975
Palisade Bio
PALI
$339M
| $33.2K | ﹤0.01% |
+29,228
| New | +$57.5K |
|
Similar funds
QCM
Wealth Enhancement Advisory Services's Q2 2026 Portfolio in Review
As of Q2 2026, Wealth Enhancement Advisory Services held 4,265 positions worth $59.8B, up 22% from $49.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Wealth Enhancement Advisory Services deployed $5.19B of net new capital in Q2 2026, opening 679 new positions and adding to 2,387 existing holdings. Its largest new stake was FIS Bright Portfolios Core Bond ETF: 1,481,683 shares worth $36.9M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 7.5% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Booking.com, an estimated $490M trimmed.
- Wealth Enhancement Advisory Services's largest Q2 2026 buy was FIS Bright Portfolios Core Bond ETF: 1,481,683 shares worth $36.9M.
- Wealth Enhancement Advisory Services added most to Micron Technology in Q2 2026, an estimated $324M increase.
- Wealth Enhancement Advisory Services's biggest Q2 2026 reduction was Booking.com, cutting an estimated $490M.
- Wealth Enhancement Advisory Services fully exited Xtrackers Risk Managed USD High Yield Strategy ETF in Q2 2026, selling an estimated $23.1M.
- Wealth Enhancement Advisory Services's ten largest holdings make up 24% of its $59.8B portfolio in Q2 2026.
- Wealth Enhancement Advisory Services opened 679 new positions and closed 129 in Q2 2026.
- Wealth Enhancement Advisory Services's portfolio value rose 22% quarter-over-quarter to $59.8B.
Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.